ReviewBiomedicines2022

Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and Limitations.

Karina Spunde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.